Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck. 1998

K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
Department of Pathology, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.

To study the role of Src family tyrosine kinases in infection with human immunodeficiency virus type 1 (HIV-1), we constructed an Hck mutant, HckN, that hinders signaling from wild-type Hck. HIV-1 produced in HckN-expressing cells was significantly less infectious to HeLa-CD4-LTR-beta-gal (MAGI) cells than HIV-1 produced in mock-transfected cells. The inhibitory effect of HckN was compensated for by the expression of vesicular stomatitis virus G protein. Finally, we found that the HIV-1 produced in the HckN-expressing cells entered into the cells less efficiently than did the control HIV-1. These results suggest that the Src family tyrosine kinases regulate entry of HIV-1 into target cells.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014771 Virion The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos. Virus Particle,Viral Particle,Viral Particles,Particle, Viral,Particle, Virus,Particles, Viral,Particles, Virus,Virions,Virus Particles
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015693 Gene Products, nef Products of the retroviral NEF GENE. They play a role as accessory proteins that influence the rate of viral infectivity and the destruction of the host immune system. nef gene products were originally found as factors that trans-suppress viral replication and function as negative regulators of transcription. nef stands for negative factor. nef Gene Products,nef Protein,3'-orf Protein,Gene Product, nef,3' orf Protein,nef Gene Product
D051572 Proto-Oncogene Proteins c-hck Members of the src-family tyrosine kinase family that are strongly expressed in MYELOID CELLS and B-LYMPHOCYTES. Proto-Oncogene Protein c-hck,c-hck Proteins,hck Proto-Oncogene Proteins,Hematopoietic Cell Kinase,Proto-Oncogene Protein hck,Tyrosine-Protein Kinase HCK,c-hck Proto-Oncogene Proteins,Proto Oncogene Protein c hck,Proto Oncogene Protein hck,Proto Oncogene Proteins c hck,Proto-Oncogene Proteins, c-hck,Proto-Oncogene Proteins, hck,Tyrosine Protein Kinase HCK,c hck Proteins,c hck Proto Oncogene Proteins,c-hck, Proto-Oncogene Protein,hck Proto Oncogene Proteins
D054311 nef Gene Products, Human Immunodeficiency Virus Proteins encoded by the NEF GENES of the HUMAN IMMUNODEFICIENCY VIRUS. nef Protein, Human Immunodeficiency Virus,HIV-3'-orf Protein,nef Protein, HIV,HIV 3' orf Protein,HIV nef Protein

Related Publications

K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
May 2018, Viruses,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
August 1995, Journal of virology,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
October 1995, Proceedings of the National Academy of Sciences of the United States of America,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
May 2005, Journal of virology,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
September 2006, Antimicrobial agents and chemotherapy,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
November 2001, Journal of virology,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
January 2004, Journal of virology,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
July 2001, Virology,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
March 2004, Journal of biochemistry,
K Tokunaga, and E Kiyokawa, and M Nakaya, and N Otsuka, and A Kojima, and T Kurata, and M Matsuda
March 2010, AIDS research and therapy,
Copied contents to your clipboard!